75000 - Document - Document and Entity Information
link:presentationLink
link:calculationLink
link:definitionLink
75010 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS
link:presentationLink
link:calculationLink
link:definitionLink
75020 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)
link:presentationLink
link:calculationLink
link:definitionLink
75030 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
link:presentationLink
link:calculationLink
link:definitionLink
75040 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Parenthetical)
link:presentationLink
link:calculationLink
link:definitionLink
75050 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
link:presentationLink
link:calculationLink
link:definitionLink
75060 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
link:presentationLink
link:calculationLink
link:definitionLink
995455 - Disclosure - Operations
link:presentationLink
link:calculationLink
link:definitionLink
995465 - Disclosure - Summary of Significant Accounting Policies
link:presentationLink
link:calculationLink
link:definitionLink
995475 - Disclosure - Revenue
link:presentationLink
link:calculationLink
link:definitionLink
995485 - Disclosure - Prepaid Expenses and Other Current Assets
link:presentationLink
link:calculationLink
link:definitionLink
995495 - Disclosure - Inventory
link:presentationLink
link:calculationLink
link:definitionLink
995505 - Disclosure - Accrued Expenses
link:presentationLink
link:calculationLink
link:definitionLink
995515 - Disclosure - Leases
link:presentationLink
link:calculationLink
link:definitionLink
995525 - Disclosure - Loan Agreements
link:presentationLink
link:calculationLink
link:definitionLink
995535 - Disclosure - Stockholders' Equity
link:presentationLink
link:calculationLink
link:definitionLink
995545 - Disclosure - Share-Based Payment Awards
link:presentationLink
link:calculationLink
link:definitionLink
995555 - Disclosure - License and Asset Purchase Agreements
link:presentationLink
link:calculationLink
link:definitionLink
995565 - Disclosure - Restructuring Charges
link:presentationLink
link:calculationLink
link:definitionLink
995575 - Disclosure - Fair Value Measurements
link:presentationLink
link:calculationLink
link:definitionLink
995585 - Disclosure - Segment Information
link:presentationLink
link:calculationLink
link:definitionLink
995595 - Disclosure - Contingencies
link:presentationLink
link:calculationLink
link:definitionLink
995605 - Disclosure - Net Loss per Share
link:presentationLink
link:calculationLink
link:definitionLink
995615 - Disclosure - Related Party Transactions
link:presentationLink
link:calculationLink
link:definitionLink
995625 - Disclosure - Summary of Significant Accounting Policies (Policies)
link:presentationLink
link:calculationLink
link:definitionLink
995635 - Disclosure - Revenue (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995645 - Disclosure - Prepaid Expenses and Other Current Assets (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995655 - Disclosure - Inventory (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995665 - Disclosure - Accrued Expenses (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995675 - Disclosure - Leases (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995685 - Disclosure - Stockholders' Equity (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995695 - Disclosure - Share-Based Payment Awards (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995705 - Disclosure - Restructuring Charges (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995715 - Disclosure - Fair Value Measurements (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995725 - Disclosure - Segment Information (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995735 - Disclosure - Net Loss per Share (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995745 - Disclosure - Operations - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995755 - Disclosure - Revenue - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995765 - Disclosure - Revenue - Product Revenue Allowance and Reserves (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995775 - Disclosure - Prepaid Expenses and Other Current Assets - Schedule of Prepaid Expenses and Other Current Assets (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995785 - Disclosure - Prepaid Expenses and Other Current Assets - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995795 - Disclosure - Inventory - Schedule of Inventory (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995805 - Disclosure - Inventory - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995815 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995825 - Disclosure - Leases - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995835 - Disclosure - Leases - Supplemental Balance Sheet Related to Operating Leases (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995845 - Disclosure - Leases - Summary of Lease Expense (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995855 - Disclosure - Leases - Schedule of Future Minimum Lease Payments Under Non-Cancellable Leases (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995865 - Disclosure - Leases - Schedule of Future Minimum Lease Payments Under Non-Cancellable Leases (Detail) 2
link:presentationLink
link:calculationLink
link:definitionLink
995875 - Disclosure - Leases - Supplemental Balance Sheet Related to Finance Leases (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995885 - Disclosure - Loan Agreements - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995895 - Disclosure - Stockholders' Equity - Equity Financings - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995905 - Disclosure - Stockholders' Equity - Warrants to Purchase Common Shares - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995915 - Disclosure - Share-Based Payment Awards - Equity Incentive Plan - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995925 - Disclosure - Share-Based Payment Awards - Stock Option Activity Under Company's Equity Incentive Plan (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995935 - Disclosure - Share-Based Payment Awards - Stock Options and Performance Options - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995945 - Disclosure - Share-Based Payment Awards - Summary of Company Applied the Black-Scholes Option Pricing (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995955 - Disclosure - Share-Based Payment Awards - Summary of Information about Stock Options (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995965 - Disclosure - Share-Based Payment Awards - Time-Vested Restricted Stock Units - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995975 - Disclosure - Share-Based Payment Awards - Summary of Restricted Stock Unit Activity (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995985 - Disclosure - Share-Based Payment Awards - Employee Stock Purchase Plan - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995995 - Disclosure - Share-Based Payment Awards - Compensation Expense from Stock-Based Payment Awards (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996005 - Disclosure - Share-Based Payment Awards - Stock-Based Compensation Expense - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996015 - Disclosure - License and Asset Purchase Agreements - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996025 - Disclosure - Restructuring Charges - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996035 - Disclosure - Restructuring Charges - Schedule of Restructuring Activities Related to Plan (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996045 - Disclosure - Fair Value Measurements - Assets and Liabilities Carried at Fair Value Measured on Recurring Basis (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996055 - Disclosure - Fair Value Measurements - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996065 - Disclosure - Segment Information - Segment and Geographic Area Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996075 - Disclosure - Segment Information - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996085 - Disclosure - Contingencies - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996095 - Disclosure - Net Loss per Share - Potentially Dilutive Securities Excluded from Computation of Diluted Weighted-Average Shares (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996105 - Disclosure - Related Party Transactions - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
Weighted Average Grant Date Fair value, Vested
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value
Sales chargebacks, rebates and other revenue reserves
Accrued Sales Chargebacks Rebates And Other Revenue Reserves
Accrued sales chargebacks, rebates and other revenue reserves.
Restructuring Reserve, Total
Restructuring Reserve
Beginning balance
Ending balance
Concentration Risk Type
Concentration Risk Type [Axis]
Finance Lease, Liability
Total finance lease liabilities
Entity Incorporation, State or Country Code
Entity Incorporation, State or Country Code
Preferred stock, shares issued
Preferred Stock, Shares Issued
Loan Agreement [Line Items]
Loan Agreement [Line Items]
Loan agreement.
Long-Term Debt, Excluding Current Maturities, Total
Long-term debt
Long-Term Debt, Excluding Current Maturities
Plan Name
Plan Name [Axis]
Equity [Abstract]
Entity Current Reporting Status
Entity Current Reporting Status
YUTIQ [Member]
Y U T I Q Product [Member]
YUTIQ product.
Operating expenses:
Operating Expenses [Abstract]
Significant Other Observable Inputs (Level 2) [Member]
Fair Value, Inputs, Level 2 [Member]
Contingencies
Commitments and Contingencies Disclosure [Text Block]
Common stock, shares authorized
Common Stock, Shares Authorized
Unrealized gain (loss) on available-for-sale securities, tax
OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax
Product and Service
Product and Service [Axis]
Document Fiscal Period Focus
Document Fiscal Period Focus
Schedule of Supplemental Balance Sheet Information Related to Finance Lease
Schedule Of Supplemental Balance Sheet Information Related To Finance Lease Table [Text Block]
Schedule of supplemental balance sheet information related to finance lease.
Revenue from Contract with Customer [Abstract]
Entity Shell Company
Entity Shell Company
Other
Other Accrued Liabilities, Current
SEC Schedule, 12-09, Valuation Allowances and Reserves Type
SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]
Watertown, Massachusetts [Member]
Watertown, Massachusetts [Member]
Watertown, Massachusetts.
Cash and Cash Equivalents, at Carrying Value, Total
Cash and cash equivalents
Cash and Cash Equivalent
Provision related to sales in the current year
Contract With Customer Allowance For Credit Loss Additions
Contract with customer allowance for credit loss additions.
Litigation Settlement, Fee Expense
Legal expense related to possible settlement
Ocumension Therapeutics.
Ocumension Therapeutics [Member]
Ocumension Therapeutics [Member]
Common stock, shares issued
Balance, shares
Balance, shares
Common Stock, Shares, Issued
Lease description
Lessee, Operating Lease, Description
Asset Class
Asset Class [Domain]
Statement [Table]
Statement [Table]
Lease liability arising from obtaining right-of-use assets
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Other Liability, Related Party [Extensible Enumeration]
Weighted-average grant date fair value per share
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Price of common stock purchased twice a year under ESPP, percent
Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent
Statement [Line Items]
Statement [Line Items]
Weighted Average Exercise Price, Expired
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price
Warrants [Member]
Warrant [Member]
Entity Filer Category
Entity Filer Category
RPA [Member]
Royalty Purchase Agreement [Member]
Royalty purchase agreement.
Total liabilities and stockholders' equity
Liabilities and Equity
Payables and Accruals [Abstract]
Credit Concentration Risk [Member]
Credit Concentration Risk [Member]
Purchases of marketable securities
Payments to Acquire Marketable Securities
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Weighted Average Exercise Price, Exercisable at September 30, 2025
Restructuring Type [Axis]
Long-Lived Tangible Asset [Axis]
Number of diseases
Number of diseases
Interest-bearing cash equivalent consisted of investment-grade U.S.Treasury securities
US Government Securities, at Carrying Value
Price per share
Shares Issued, Price Per Share
Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]
Increase in ROU assets
Increase Decrease In Operating Right of Use Assets
Increase decrease in operating right of use assets.
Increase in right-of-use assets
Clinical trial costs
Accrued Clinical Expense Current
Carrying value as of the balance sheet date of estimated obligations incurred through that date and payable for obligations related to services of contract research organizations in conducting clinical trials.
Geographical
Geographical [Domain]
Prepaid Expenses and Other Current Assets
Other Current Assets [Text Block]
Segment and Geographic Area Information
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]
Schedule of Inventory
Schedule of Inventory, Current [Table Text Block]
Percentage of inventory balance
Percentage of Inventory Balance
Percentage of inventory balance.
Additional paid-in capital
Additional Paid in Capital, Common Stock
Adjustments related to prior period sales
Contract With Customer Allowance For Credit Loss Increase Decrease
Contract with customer allowance for credit loss increase decrease.
Summary of Significant Accounting Policies
Significant Accounting Policies [Text Block]
Loan Agreement [Table]
Loan Agreement [Table]
Loan agreement.
Exclusive license agreement with betta pharmaceuticals company limited.
Exclusive License Agreement with Betta Pharmaceuticals, Co., Ltd.
Exclusive License Agreement With Betta Pharmaceuticals Company Limited [Member]
Vesting [Domain]
Number of Options, Granted
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross
Disaggregation Of Revenue [Table]
Disaggregation of Revenue [Table]
Stock Compensation Plan [Member]
Share-Based Payment Arrangement [Member]
Net loss per share - basic
Earnings Per Share, Basic
Earnings Per Share, Basic, Total
Product rights agreement and the supply agreement.
Product Rights Agreement and the Supply Agreement [Member]
Product Rights Agreement and the Supply Agreement [Member]
Repayments of Long-Term Debt, Total
Payment of long-term debt
Repayments of Long-Term Debt
Lessee Operating Lease Liability Payments Due After Year Three
Lessee operating lease liability payments due after year three.
Thereafter
Ramiro Ribeiro [Member]
Ramiro Ribeiro.
Ramiro Ribeiro
Northbridge, Massachusetts [Member]
Northbridge, Massachusetts.
Number of Options Outstanding, Beginning balance
Number of Options Outstanding, Ending balance
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Repayment of senior secured term loan
Repayments of Secured Debt
Total current liabilities
Liabilities, Current
Adjustments to reconcile net loss to cash flows used in operating activities:
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]
Number of renewal options
Number Of Renewal Options
Number of renewal options.
Finished goods
Inventory, Finished Goods, Net of Reserves
Warrants were exercised in cashless exercise
Cashless exercise of warrants, shares
Stock Issued During Period, Shares, Cashless Exercise Of Warrants
Stock issued during period, shares, cashless exercise of warrants.
Equity Incentive Plans [Member]
Equity Incentive Plans [Member]
Equity incentive plans.
Two thousand twenty three restructuring plan.
Two Thousand Twenty Three Restructuring Plan [Member]
2023 Restructuring Plan [Member]
Stockholders' equity:
Equity, Attributable to Parent [Abstract]
Entity Small Business
Entity Small Business
Accumulated deficit
Retained Earnings (Accumulated Deficit), Total
Retained Earnings (Accumulated Deficit)
Net Proceeds from Equity Financing
Net proceeds from equity financing.
Net proceeds from equity financing
Operations
Nature of Operations [Text Block]
Proceeds from Stock Options Exercised and Employee Stock Purchase Plan
Proceeds from stock options exercised and employee stock purchase plan.
Proceeds from exercise of stock options and employee stock purchase plan
Number of Options, Forfeited
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period
Total intrinsic value of stock options exercised
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value
Share-Based Payment Awards
Share-Based Payment Arrangement [Text Block]
Amortization of debt discount and premium and discount on available-for-sale marketable securities
Amortization Of Debt Discount And Premium And Discount On Available For Sale Marketable Securities
Amortization of debt discount and premium and discount on available-for-sale marketable securities.
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Laboratory equipment.
Laboratory equipment [Member]
Laboratory Equipment [Member]
Leases [Abstract]
Prepaid Clinical Current
Prepaid clinical current.
Prepaid clinical
Lessee, Lease, Description [Line Items]
Amendment Flag
Amendment Flag
Product and Service
Product and Service [Domain]
Inventory
Inventory Disclosure [Text Block]
Due to license and collaboration agreements.
Due to License And Collaboration Agreements
Due to Alimera (see Note 3)
Liabilities and stockholders' equity
Liabilities and Equity [Abstract]
Entity Address, Postal Zip Code
Entity Address, Postal Zip Code
Net cash (used in) provided by operating activities
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Increase in lease liabilities
Increase (Decrease) in Operating Lease Liability
New Premises [Member]
New Premises [Member]
New premises.
Warrants exercise period
Warrants Exercise Period
Warrants exercise period.
Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description
Common Stock [Member]
Common Stock [Member]
Commissions due to DEXYCU commercial partner
Accrued Liabilities for Commissions, Expense and Taxes
Weighted Average Exercise Price, Granted
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Lessee, Operating Lease, Liability, to be Paid, Year Three
2029
Guaranteed payments.
Guaranteed Payments
Guaranteed payments
Debt instrument effective rate
Debt Instrument, Interest Rate, Effective Percentage
Entity Address, Address Line One
Entity Address, Address Line One
Schedule of Key Assumptions Used
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
Fair Value Hierarchy and NAV
Fair Value Hierarchy and NAV [Axis]
Earnings Per Share [Abstract]
Supplemental cash flow information:
Supplemental Cash Flow Information [Abstract]
Collaborative Agreements And Contracts [Line Items]
Collaborative Agreements And Contracts [Line Items]
Collaborative agreements and contracts.
ROU assets
Operating lease right-of-use assets
Operating Lease, Right-of-Use Asset
Inventory Disclosure [Abstract]
Document Type
Document Type
Collaborative Arrangement and Arrangement Other than Collaborative
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Equity Incentive Plans And Inducement Award Grants [Member]
Equity incentive plans and inducement award grants.
Equity Incentive Plan and Inducement Awards [Member]
Collaborative Arrangement and Arrangement Other than Collaborative
Collaborative Arrangement and Arrangement Other than Collaborative [Domain]
Entity Central Index Key
Entity Central Index Key
2016 Long Term Incentive Plan [Member]
Two Thousand Sixteen Incentive Plan [Member]
Two thousand sixteen incentive plan.
Prime Rate Margin [Member]
Prime Rate [Member]
Net (decrease) increase in cash, cash equivalents and restricted cash
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
Subsequent Event Type [Domain]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Total
Common stock, par value
Common Stock, Par or Stated Value Per Share
Interest-bearing cash equivalent consisted of money market fund
Money Market Funds, at Carrying Value
Annual Basis [Member]
Share-Based Payment Arrangement, Tranche One [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term
Weighted Average Remaining Contractual Life, Outstanding at September 30, 2025
Restructuring and Related Activities, Initiation Date
Restructuring plan executed date
Stock volatility, maximum
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum
Carrying Value
Debt Securities, Available-for-Sale, Amortized Cost
Debt Securities, Available-for-Sale
Fair Value
Initial term of the supply agreement.
Initial Term of the Supply Agreement
Initial term of the supply agreement
Number of Options, Exercised
Exercise of stock options, shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period
Debt Disclosure [Abstract]
Disclosure of Leases
Disclosure Of Leases [Line Items]
Disclosure Of Leases [Line Items]
Stock option and restricted stock awards.
Stock Option and Restricted Stock Awards [Member]
Total accrued expenses
Accrued expenses
Accrued Liabilities, Current
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Current Fiscal Year End Date
Current Fiscal Year End Date
Senior Secured Term Loan [Member]
Senior Secured Term Loan [Member]
Senior secured term loan.
Initial term of estimated supply units.
Initial Term of Estimated Supply Units
Initial term of estimated supply units
Restricted Cash and Cash Equivalents, Noncurrent, Total
Restricted cash
Restricted Cash and Cash Equivalent, Noncurrent
Document Quarterly Report
Document Quarterly Report
Entity Address, State or Province
Entity Address, State or Province
Stock issuances, sales agent commission maximum percentage
Stock Issuance Costs Sales Agent Commission Maximum Percentage
Stock issuance costs sales agent commission maximum percentage.
Product Rights Agreement Date
Product rights agreement date.
Product rights agreement date
Number of Stock Units Outstanding, Beginning Balance
Number of Stock Units Outstanding, Ending Balance
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Preferred Stock, Shares Outstanding, Ending Balance
Preferred Stock, Shares Outstanding, Beginning Balance
Preferred stock, shares outstanding
Preferred Stock, Shares Outstanding
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive loss
Gross Unrealized Gains
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax
DEXYCU [Member]
D E X Y C U Product [Member]
DEXYCU product.
Geographical
Geographical [Axis]
Line of Credit Facility, Lender
Line of Credit Facility, Lender [Domain]
Legal, corporate and professional expenses
Legal, corporate and professional expenses.
Legal, corporate and professional expenses
Marketable Securities
Marketable securities
Marketable Securities, Current
Product Revenue Allowances and Reserves
Product Revenue Allowance And Reserve Table [Text Block]
The tabular disclosure of product revenue allowance and reserve.
Senior Secured Revolving Credit Facility and Senior Secured Term Loan[Member]
Senior Secured Revolving Credit Facility And Senior Secured Term Loan [Member]
Senior secured revolving credit facility' and senior secured term loan.
Royalty payments
Payments for Royalties
One Time Payment of Net Revenue
One time payment of net revenue.
One-time payment
Compensation Expense from Stock-Based Payment Awards
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
Exercise of stock options
Stock Issued During Period, Value, Stock Options Exercised
License and Asset Purchase Agreements
Collaborative Arrangement Disclosure [Text Block]
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Other comprehensive gain (loss):
Sales and maturities of marketable securities
Proceeds from Sale and Maturity of Marketable Securities
Subsequent Event [Member]
Subsequent Event [Member]
Stock issuance costs
Non Cash Unpaid Stock Issuance Costs
Noncash unpaid stock issuance costs.
Senior Secured Revolving Credit Facility [Member]
Senior Secured Revolving Credit Facility [Member]
Senior secured revolving credit facility.
Deferred Revenue, Current, Total
Deferred revenue
Deferred Revenue, Current
Other assets
Other Assets, Noncurrent
Organization And Nature Of Business [Table]
Organization And Nature Of Business [Table]
Organization And Nature Of Business [Table]
Antidilutive Securities
Antidilutive Securities [Axis]
Two thousand twenty three incentive plan.
Two Thousand Twenty Three Incentive Plan [Member]
2023 Long Term Incentive Plan [Member]
Number of Options, Expired
Number of Options, Expired
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage
Award vesting percentage
Eyebiotech License Agreement [Member]
Eyebio License Agreement [Member]
Eyebio license agreement.
Renewal term of supply agreement.
Renewal Term Of Supply Agreement
Renewal term of supply agreement
AOCI Attributable to Parent [Member]
Accumulated Other Comprehensive Income (loss) [Member]
Silicon Valley Bank [Member]
Silicon Valley Bank [Member]
Silicon valley bank.
Cash and Cash Equivalents
Cash and Cash Equivalents [Domain]
Lease option to extend
Lessee, Operating Lease, Option to Extend
Preferred stock, $.001 par value, 5,000,000 shares authorized, no shares issued and outstanding
Preferred Stock, Value, Issued
Payment of extinguishment of debt costs
Payment of exit fee
Payment for Debt Extinguishment or Debt Prepayment Cost
Investment Instruments [Member]
Investment Instruments [Member]
Investment instruments.
Property and equipment, at cost
Finance Lease Property And Equipment Gross
Finance lease property and equipment gross.
Minimum [Member]
Minimum [Member]
Weighted Average Grant Date Fair Value, Granted
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
Financial Instrument
Financial Instrument [Axis]
Current assets:
Assets, Current [Abstract]
Segment Reporting [Abstract]
Assets and Liabilities Carried at Fair Value Measured on Recurring Basis
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]
Current liabilities:
Liabilities, Current [Abstract]
Product [Member]
Product [Member]
Product sales, net [Member]
Restructuring and Related Activities Disclosure [Text Block]
Restructuring Charges
Related Party Transactions [Abstract]
ANI pharmaceuticals inc.
ANI Pharmaceuticals Inc [Member]
ANI Pharmaceuticals, Inc. [Member]
Additional lease renewal option period
Lessee, Operating Lease, Renewal Term
Commitments and Contingencies
Contingencies (Note 12)
SEC Schedule, 12-09, Valuation Allowances and Reserves
SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]
Weighted Average Grant Date Fair Value Nonvested, Beginning balance
Weighted Average Grant Date Fair Value Nonvested, Ending balance
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
General and Administrative [Member]
General and Administrative Expense [Member]
General and Administrative Expense [Member]
Lease liabilities
Total operating lease liabilities
Total
Operating Lease, Liability
Work in process
Inventory, Work in Process, Net of Reserves
Revolving line bears interest rate
Prime rate margin
Debt Instrument, Basis Spread on Variable Rate
Forecast [Member]
Scenario, Forecast [Member]
Short-Term Debt, Total
Short-term borrowings
Short-Term Debt
Concentration Risk Benchmark
Concentration Risk Benchmark [Axis]
Other current liabilities - finance lease current portion
Finance Lease, Liability, Current
Lessee, Lease, Description [Table]
Schedule of Restructuring Reserve by Type of Cost [Table Text Block]
Schedule of Restructuring Activities Related to Plan
Property and equipment additions in accounts payable and accrued expenses
Capital Expenditures Incurred but Not yet Paid
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total
Net loss
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Weighted average common shares outstanding - basic
Weighted Average Number of Shares Outstanding, Basic
Weighted Average Number of Shares Outstanding, Basic, Total
Scenario
Scenario [Axis]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value
Aggregate Intrinsic Value, Exercisable at September 30, 2025
Operating Leases
Leases, Operating [Abstract]
Share-Based Payment Arrangement, Plan Modification, Incremental Cost
Incremental expense
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Long-Lived Tangible Asset [Domain]
Stock units granted, net of units withheld for tax, shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures, Total
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]
Raw materials
Inventory, Raw Materials, Net of Reserves
Related Party Transactions
Related Party Transactions Disclosure [Text Block]
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition, Total
Stock-based compensation
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
Variable Rate
Variable Rate [Domain]
Total stockholders' equity
Balance
Balance
Equity, Attributable to Parent
Preferred stock, par value
Preferred Stock, Par or Stated Value Per Share
Lease existence of option to extend
Lessee, Operating Lease, Existence of Option to Extend [true false]
Statement of Stockholders' Equity [Abstract]
Disclosure Of Leases [Table]
Disclosure Of Leases [Table]
Disclosure of Leases
Type of Restructuring [Domain]
Personnel expense (including stock based compensation)
Personnel expense (including stock based compensation)
Personnel expense (including stock based compensation)
Sales and Marketing Expense [Member]
Selling and Marketing Expense [Member]
Fair Value Measurements
Fair Value Disclosures [Text Block]
Schedule of Accrued Expenses
Schedule of Accrued Liabilities [Table Text Block]
Other
Other Assets, Current
Supplemental disclosure of non-cash investing and financing activities:
Noncash Investing and Financing Items [Abstract]
Inventory, Current [Table]
Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]
Weighted average remaining vesting term
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested Weighted Average Remaining Contractual Term
Share based compensation arrangement by share based payment award equity instruments other than options vested weighted average remaining contractual term.
Segment Reporting, Other Segment Item, Amount
Other segment expenses
Other segment expenses
Plan Name
Plan Name [Domain]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Credit Facility
Credit Facility [Axis]
Milestone payments to be received
Milestone Payments to be Received
Milestone payments to be received.
Restructuring Plan [Axis]
Alimera Sciences, Inc.
Alimera Sciences, Inc. [Member]
Alimera Sciences, Inc. [Member]
Related Party
Related and Nonrelated Parties [Axis]
Area of property covered
Area of Real Estate Property
Entity Address, City or Town
Entity Address, City or Town
Security Exchange Name
Security Exchange Name
Credit Facility
Credit Facility [Domain]
Schedule of Supplemental Balance Sheet Information Related to Operating Leases
Schedule Of Supplemental Balance Sheet Information Related To Operating Leases Table [Text Block]
Schedule of supplemental balance sheet information related to operating leases.
Concentration Risk Type
Concentration Risk Type [Domain]
Antidilutive Securities, Name
Antidilutive Securities, Name [Domain]
Stockholders' Equity Note [Abstract]
Total inventory
Inventory
Inventory, Net
Total cash, cash equivalents and restricted cash at end of period
Cash, cash equivalents and restricted cash at beginning of period
Cash, cash equivalents and restricted cash at end of period
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation
Cash interest paid
Interest Paid, Excluding Capitalized Interest, Operating Activity
Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]
Statistical Measurement
Statistical Measurement [Domain]
Class of Warrant or Right, Exercise Price of Warrants or Rights
Weighted average exercise price of warrants
Total current assets
Assets, Current
Total stock-based compensation expense
Stock-based compensation expense
Share-Based Payment Arrangement, Expense
Document Period End Date
Document Period End Date
Fair Value Hierarchy and NAV
Fair Value Hierarchy and NAV [Domain]
Pre Funded Warrants Shares Included in Net Income Loss Per Share Calculation
Pre-funded warrants shares included in net income loss per share calculation.
Pre-funded warrants shares included in net loss per share calculations
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number
Number of Options, Exercisable at September 30, 2025
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]
Loan Agreements
Long-Term Debt [Text Block]
U.S. Agency securities [Member]
U S Agency Securities.
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]
Statement of Financial Position [Abstract]
Restricted stock units [Member]
RSU [Member]
Restricted Stock Units (RSUs) [Member]
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]
Antidilutive Security, Excluded EPS Calculation [Table]
Vesting [Axis]
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation [Abstract]
Reconciliation of cash, cash equivalents and restricted cash to the condensed consolidated balance sheets:
Two thousand sixteen and two thousand twenty three incentive plan.
Two Thousand Sixteen and Two Thousand Twenty Three Incentive Plan [Member]
2016 and 2023 Long Term Incentive Plan [Member]
Total liabilities
Liabilities
Financial Instruments
Financial Instruments [Domain]
Pre Funded Warrants Outstandings
Pre funded warrants outstandings
Loss Contingency, Estimate of Possible Loss
Expense estimate in connection with possible settlement of DOJ's investigation
Line of credit facility prepayment fee percentage.
Line Of Credit Facility Prepayment Fee Percentage
Prepayment fee percentage
Lessee, Operating Lease, Liability, to be Paid, Year Two
2028
Restricted cash
Restricted Cash
Restricted Cash, Total
Variable Rate
Variable Rate [Axis]
Prepaid Expense and Other Assets, Current [Abstract]
Weighted average common shares outstanding - diluted
Weighted Average Number of Shares Outstanding, Diluted
Weighted Average Number of Shares Outstanding, Diluted, Total
Lease renewal term
Lessor, Operating Lease, Lease Not yet Commenced, Renewal Term
Entity File Number
Entity File Number
Unrealized gain (loss) on available-for-sale securities
OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax
Cover [Abstract]
Stock volatility, minimum
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum
Total prepaid expenses and other current assets
Prepaid expenses and other current assets
Prepaid Expense and Other Assets, Current
Number of Stock Units, Forfeited
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Scenario
Scenario [Domain]
U.S. Treasury Securities [Member]
US Treasury Securities [Member]
Number of common stock, authorized for issuance
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized
Number of business segments
Number of Operating Segments
Segment Reporting Disclosure [Text Block]
Segment and Geographic Area Information
General and Administrative Expense, Total
General and administrative
General and Administrative Expense
Summary of Restricted Stock Unit Activity
Nonvested Restricted Stock Shares Activity [Table Text Block]
Common stock vested during the period
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period
Shares issued
SWK [Member]
SWK Funding LLC [Member]
S W K Funding L L C [Member]
SWK Funding LLC.
Net book value at end of period
Intangible assets, net
Carrying value of internally developed intangible assets
Net intangible asset
Finite-Lived Intangible Assets, Net, Ending Balance
Finite-Lived Intangible Assets, Net, Beginning Balance
Loss on extinguishment of debt
Loss on extinguishment of debt
Gain (Loss) on Extinguishment of Debt, Total
Loss on extinguishment of debt
Gain (Loss) on Extinguishment of Debt
License and Collaboration Agreement [Member]
License and Collaboration Agreements [Member]
License And Collaboration Agreement [Member]
License and collaboration agreement.
Cost of sales
Cost of sales excluding amortization of acquired intangible assets.
Cost Of Sales Excluding Amortization Of Acquired Intangible Assets
Cost of sales, excluding amortization of acquired intangible assets
Restructuring Charges, Total
Restructuring Charges
Restructuring charges
New Accounting Pronouncements, Policy [Policy Text Block]
Recent Accounting Pronouncements
Schedule of Future Minimum Lease Payments Under Non-Cancellable Leases
Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]
ESPP [Member]
ESPP [Member]
Employee Stock Purchase Plan [Member]
Employee stock purchase plan.
Massachusetts [Member]
Ma [Member]
MA
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Deferred revenue, current
Contract with Customer, Liability, Current
Ratable annual vesting period of equity awards
Ratable monthly vesting period
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period
Employee Severance [Member]
Employee Severance [Member]
Right-of-use assets and operating lease liabilities
Increase Decrease In Operating Lease Liabilities And Right Of Use Asset
Increase or decrease in operating lease liability and right of use asset.
Risk-free interest rate, minimum
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum
Commercial supply agreement.
Commercial Supply Agreement [Member]
Supply Agreement [Member]
Original lease term
Lessee, Operating Lease, Term of Contract
Common Stock, Shares, Outstanding, Ending Balance
Common Stock, Shares, Outstanding, Beginning Balance
Common stock, shares outstanding
Common Stock, Shares, Outstanding
Other current liabilities – operating lease current portion
Operating Lease, Liability, Current
Depreciation of property and equipment
Depreciation, Depletion and Amortization
Depreciation, Depletion and Amortization, Total
Document Transition Report
Document Transition Report
Operating Expenses
Total operating expenses
Research and development expense
Research and Development Expense, Total
Research and development
Research and Development Expense
Pre Funded Warrants to purchase common stock
Pre Funded Warrants To Purchase Common Stock
Pre Funded Warrants to purchase common stock.
Leases
Lessee, Operating Leases [Text Block]
Statement of Cash Flows [Abstract]
Stock Option Activity Under Plan
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
At-the-Market Offering [Member]
At The Market Offering [Member]
At the market offering.
Stockholders' Equity
Equity [Text Block]
Weighted average remaining life of lender warrants
Weighted Average Remaining Life Of Lender Warrants
The weighted average remaining life of lender warrants.
Net Loss per Share
Earnings Per Share [Text Block]
Upfront cash payment
Upfront Cash Payment
Upfront cash payment.
Line of credit facility commencing date
Line Of Credit Facility Commencing Date
Line of credit facility commencing date.
share issuance, net
Shares, Issued
Net loss
Net loss
Warrants issued to purchase shares of common stock
Warrants Issued In Connection With Term Loan Facility
Warrants issued in connection with term loan facility.
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value
Aggregate Intrinsic Value, Outstanding
Inventory Write-down
Provision for excess and obsolete inventory
Increase (Decrease) in Inventories, Total
Inventory
Increase (Decrease) in Inventories
Inventory [Line Items]
Interest and other income, net
Other Nonoperating Income
Total lease expense, excluding variable lease costs
Operating Lease, Cost
Operating Lease, Cost
Expected dividends
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate
Operating lease payments
Operating Lease, Payments
Assets
Assets [Abstract]
Restructuring and Related Activities [Abstract]
Interest-bearing cash equivalent consisted of investment-grade commercial paper
Commercial Paper, at Carrying Value
Document Fiscal Year Focus
Document Fiscal Year Focus
Lease renewal rate at 95% of market rent at time of renewal
Operating Lease Renewal Term Percentage Of Market Rent At Renewal Date
Operating lease renewal term percentage of market rent at renewal date.
Concentration Risk Benchmark
Concentration Risk Benchmark [Domain]
Other direct research and development expense
Other direct research and development expense.
Other direct research and development expense
Cash flows from investing activities:
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]
Accounts Payable, Current, Total
Accounts payable
Accounts Payable, Current
Research and Development [Member]
Research and Development Expense [Member]
Research and Development Expense [Member]
Increase (Decrease) in Other Noncurrent Assets
Other assets
Restructuring Cost and Reserve [Line Items]
Disclosure Of Leases [Abstract]
Disclosure of Leases
Accounts payable
Other Liabilities
Other Liabilities, Total
Total cash received from exercise of stock options
Proceeds from exercise of stock options
Proceeds from Stock Options Exercised
Fair Value Disclosures [Abstract]
Commitments and Contingencies Disclosure [Abstract]
Lessee, Operating Lease, Liability, to be Paid, Year One
2027
Jay Duker [Member]
Jay Duker.
Jay Duker
Share-Based Payment Arrangement [Abstract]
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total
Unrecognized compensation expense
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
Percentage of concentration risk
Concentration Risk, Percentage
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Net cash (used in) provided by investing activities
Intellectual Property Expense
Intellectual property expense.
Intellectual property expense
Intellectual property expense
Title of 12(b) Security
Title of 12(b) Security
Exit fee percentage of the aggregate principal amount
Line of Credit Facility, Interest Rate at Period End
Weighted Average Exercise Price, Forfeited
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
Weighted Average Grant Date Fair value, Forfeited
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
Money Market Funds [Member]
Money Market Funds [Member]
Related Party
Related and Nonrelated Parties [Domain]
Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year
2026
Other Liabilities, Noncurrent
Other noncurrent liabilities
Restructuring Plan [Domain]
Finance Lease, Right-of-Use Asset, after Accumulated Amortization
Property and equipment, net
Changes in operating assets and liabilities:
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]
Weighted Average Exercise Price Outstanding, Beginning balance
Weighted Average Exercise Price Outstanding, Ending balance
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]
Fair Value, Recurring and Nonrecurring [Table]
Payment upon achievement of development and regulatory milestones
Milestone Payments Upon Achievement Of Certain Development And Regulatory Milestones
Milestone payments upon achievement of certain development and regulatory milestones.
Additional Paid-In Capital [Member]
Additional Paid-in Capital [Member]
Accumulated amortization
Finance Lease Accumulated Amortization Property And Equipment
Finance lease accumulated amortization property and equipment.
Accounts payable and accrued expenses
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
Measurement Frequency
Measurement Frequency [Domain]
Altasciences Company Inc [Member]
Altasciences Company Inc [Member]
Altasciences Company Inc.
Income Statement Location
Statement of Income Location, Balance [Axis]
Summary of Information about Stock Options
Schedule of Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value [Table Text Block]
Trading Symbol
Trading Symbol
Related Party Transaction [Table]
Prepaid Clinical Expense Noncurrent
Prepaid clinical expense noncurrent.
Prepaid clinical expense
Risk-free interest rate, maximum
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum
Subsequent Event Type [Axis]
Employee-related Liabilities, Current, Total
Personnel costs
Employee-related Liabilities, Current
Cash flows from financing activities:
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]
Option life (in years)
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term
Fair Value, Measurements, Recurring [Member]
Fair Value, Recurring [Member]
Accrued Expenses
Accounts Payable and Accrued Liabilities Disclosure [Text Block]
Total lease payments
Estimates total lease initial noncancellable amount
Lessee, Operating Lease, Liability, to be Paid
Less imputed interest
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Selling and Marketing Expense, Total
Sales and marketing
Selling and Marketing Expense
Additional Paid-In Capital [Member]
Equity Components [Axis]
Returns [Member]
Returns [Member]
Returns.
Nonoperating Income (Expense)
Total other income, net
Equity Component
Equity Component [Domain]
Asset Class
Asset Class [Axis]
Deferred Revenue, Noncurrent, Total
Deferred revenue - noncurrent
Deferred Revenue, Noncurrent
Payment Of Accrued And Unpaid Interest
Payment of accrued and unpaid interest through the date of the secured term loan refinancing
Payment accrued and unpaid interest through the date of the secured term loan refinancing
Sales and Marketing [Member]
Sales And Marketing [Member]
Sales and marketing.
Equinox Science, LLC [Member]
Equinox Science L L C [Member]
Equinox science, LLC.
Employee stock purchase plan, shares
Employee stock purchase plan, shares
Stock Issued During Period, Shares, Employee Stock Purchase Plans
Contractual life of option grants
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period
Depreciation, Depletion and Amortization, Nonproduction, Total
Depreciation, Depletion and Amortization, Nonproduction
Depreciation and amortization
Depreciation and amortization
Accounts and other receivables, net
Accounts and Other Receivables, Net, Current
Sale of YUTIQ Franchise
Sale of YUTIQ franchise
Sale of YUTIQ franchise.
Maximum [Member]
Maximum [Member]
Statistical Measurement
Statistical Measurement [Axis]
Weighted Average Exercise Price, Exercised
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Deferred revenue, non-current
Contract with Customer, Liability, Noncurrent
Prepaid expenses
Prepaid Expense, Current
Prepaid Expense, Current, Total
Chargebacks, Discounts and Fees [Member]
Charge Backs And Discounts And Fees [Member]
Charge backs and discounts and fees.
Common Stock, Value, Issued
Common stock, $.001 par value, 300,000,000 shares authorized at March 31, 2026 and December 31, 2025; 83,439,831 and82,826,416 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively
Reduction of expense
share based compensation arrangement by share based payment award plan modification reduction compensation cost.
Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Reduction Compensation Cost
DURAVYU Direct Research And Development Expense
DURAVYU direct research and development expense
DURAVYU direct research and development expense.
DURAVYU direct research and development expense
Principal payments on finance lease obligations
Finance lease, financing cash flows
Finance Lease, Principal Payments
Maturity date
Line of Credit Facility, Expiration Date
Royalty [Member]
Royalty Income [Member]
Accounts receivable and other current assets
Increase (Decrease) in Accounts Receivable and Other Operating Assets
Payment of exit fee upon repayment of secured term loan
Deb Instrument Exit Fee
Exit Fee Charged
Cliff vesting period
Share Based Compensation Arrangement By Share Based Payment Award Cliff Vesting Period
Share based compensation arrangement by share based payment award cliff vesting period.
Operations [Line Items]
Operations [Line Items]
Operations.
Disclosure Of Product Revenue Reserves And Allowances [Line Items]
Disclosure Of Product Revenue Reserves And Allowances [Line Items]
Disclosure of product revenue reserves and allowances.
Preferred stock, shares authorized
Preferred Stock, Shares Authorized
Net settlement of stock units to satisfy statutory tax withholding
Payment, Tax Withholding, Share-Based Payment Arrangement
Lender Name
Lender Name [Axis]
Loss Contingency Accrual, Period Increase (Decrease)
Loss Contingency Accrual, Period Increase (Decrease), Total
Legal expense related to possible settlement during period
Related Party Transaction [Line Items]
Revenue
Revenue from Contract with Customer [Text Block]
Entity Registrant Name
Entity Registrant Name
Gross Unrealized Losses
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax
Interest and other income, net
Other Nonoperating Income (Expense)
Other Nonoperating Income (Expense), Total
Accrued Professional Fees, Contingencies And Legal Fees Current
Accrued professional fees, contingencies and legal fees current.
Professional fees, contingencies and legal fees
Rule 10b5-1 Arrangement Modified [Flag]
Rule 10b5-1 arrangement modified.
Rule 10b5-1 Arrangement Modified
Income Tax Expense (Benefit)
Income Tax Expense (Benefit), Total
Provision for income taxes
Provision for income taxes
Measurement Frequency
Measurement Frequency [Axis]
Equity Financings [Member]
Equity Financings [Member]
Equity financings.
Gross proceeds from issuance of common stock
Proceeds from Issuance of Common Stock
Proceeds from issuance of stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Lease inception date.
Lease Inception Date
Lease commencement date
Entity Common Stock, Shares Outstanding
Entity Common Stock, Shares Outstanding
Receipt of upfront license fee
Upfront License Fee Received
Upfront cash payment received under license agreement.
Accumulated Other Comprehensive Income (Loss), Net of Tax, Total
Accumulated Other Comprehensive Income (Loss), Net of Tax
Accumulated other comprehensive income (loss)
Payments for Restructuring
Cash payments
Payments to Acquire Property, Plant, and Equipment, Total
Purchases of property and equipment
Payments to Acquire Property, Plant, and Equipment
Number of Stock Units, Granted
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period
Line of credit facility statement fee termination fee and unused credit fee amount.
Line Of Credit Facility Statement Fee Termination Fee And Unused Credit Fee Amount
Line of credit facility statement fee, termination fee and unused credit fee amount
Total assets
Assets
Disclosure Of Product Revenue Reserves And Allowances [Table]
Disclosure Of Product Revenue Reserves And Allowances [Table]
Disclosure of Product Revenue Reserves and Allowances
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term
Weighted Average Remaining Contractual Life, Exercisable at September 30, 2025
Income Statement [Abstract]
Restructuring Cost [Table]
Number of consecutive equal monthly installment
Number Of Consecutive Equal Monthly Installments
Number of consecutive equal monthly installments.
Deferred Income Tax Expense (Benefit)
Deferred Income Tax Expense (Benefit), Total
Deferred income tax
Non-refundable and non-creditable upfront cash payment
Non Refundable Non Creditable Upfront Cash Payment
Non-refundable, non-creditable upfront cash payment.
Net issuance of common shares
Common stock issued
Issuance of stock, net of issue costs, shares
Lease expense included in:
Lease, Cost [Abstract]
Number of Stock Units, Vested
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period
Net loss per share - diluted
Earnings Per Share, Diluted
Earnings Per Share, Diluted, Total
City Area Code
City Area Code
Non Cash Unpaid Stock Issuance Costs in Accounts Payable and Accrued Expenses
Non cash unpaid stock issuance costs in accounts payable and accrued expenses.
Stock issuance costs in accounts payable and accrued expenses
Finance Lease, Liability, Noncurrent
Other long-term liabilities
Proceeds from Lines of Credit, Total
Proceeds from issuance of revolving facility
Borrowings under revolving facility
Proceeds from Lines of Credit
Product rights agreement.
Product Rights Agreement [Member]
Product Rights Agreement [Member]
Product Sales, License and Collaboration Revenue, or Royalty Income [Member]
Product sales license and collaboration revenue or royalty income.
Variable lease cost
Variable Lease, Cost
Employee stock purchase plan
Employee stock purchase plan
Stock Issued During Period, Value, Employee Stock Purchase Plan
Operating lease weighted average remaining lease term
Operating Lease, Weighted Average Remaining Lease Term
Government and Other Rebates [Member]
Governments And Other Rebates [Member]
Governments and other rebates.
Investor [Member]
Investor [Member]
Lease term expiration date
Lease Expiration Date
Total lease expense
Lease, Cost
Property, Plant and Equipment, Net, Total
Property and equipment, net
Property, Plant and Equipment, Net
Loss from operations
Operating Income (Loss)
Accumulated Deficit [Member]
Retained Earnings [Member]
Operations [Abstract]
Operations [Abstract]
Cash and Cash Equivalents
Cash and Cash Equivalents [Axis]
Share-Based Payment Arrangement, Noncash Expense, Total
Share-Based Payment Arrangement, Noncash Expense
Stock-based compensation
Payment of equity issue costs
Share issuance costs
Payments of Stock Issuance Costs
Net proceeds of issuance costs
Performance Options [Member]
Performance Options [Member]
Performance options.
Collaborative Agreements And Contracts [Table]
Collaborative Agreements And Contracts [Table]
Collaborative agreements and contracts.
Consecutive six month offering period
Share Based Compensation Arrangement By Share Based Payment Award Consecutive Six Month Offering Period
Share based compensation arrangement by share based payment award consecutive six month offering period.
Operating Lease, Weighted Average Discount Rate, Percent
Operating lease weighted average discount rate
Operating lease liabilities - noncurrent portion
Operating lease liabilities - noncurrent
Operating Lease, Liability, Noncurrent
Quoted Prices in Active Markets (Level 1) [Member]
Fair Value, Inputs, Level 1 [Member]
Class of Stock [Line Items]
Class Of Stock [Line Items]
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Net cash (used in) provided by financing activities
Summary of Lease Expense
Lease, Cost [Table Text Block]
Royalties payment period
Royalties payment period.
Royalties Payment Period
Schedule of Prepaid Expenses and Other Current Assets
Schedule of Other Current Assets [Table Text Block]
Summary of Reconciliation of Warrants to Purchase Common Stock
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]
Nonoperating Income (Expense) [Abstract]
Other (expense) income:
Deductions applied and payments made
Contract With Customer Allowance For Deductions Applied And Payments Made
Contract with customer allowance for deductions applied and payments made.
Potentially Dilutive Securities Excluded from Computation of Diluted Weighted-Average Shares
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
Entity Interactive Data Current
Entity Interactive Data Current
First Citizens BancShares, Inc. [Member]
First Citizens BancShares, Incorporated [Member]
First citizens bancshares, incorporated.
Deferred revenue
Increase (Decrease) in Contract with Customer, Liability
Income Statement Location
Statement of Income Location, Balance [Domain]
Cash flows from operating activities:
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]
Stock units granted, net of units withheld for tax
Shares Granted, Value, Share-Based Payment Arrangement, after Forfeiture
Shares Granted, Value, Share-Based Payment Arrangement, after Forfeiture, Total
Repayment under revolving facility
Repayments of Lines of Credit
Repayment of outstanding balance
Loss Contingency, Accrual, Current
Contingent liability
Thereafter
Lessee Operating Lease Liability Payments Due After Year Four
Lessee operating lease liability payments due after year four.
Increase (Decrease) in Other Noncurrent Liabilities
Other noncurrent liabilities
Exercise price of issued warrants
Exercise Price Of Issued Warrants
Exercise price of issued warrants.
Cash Equivalents, at Carrying Value, Total
Cash Equivalents
Cash Equivalents, at Carrying Value
Entity Tax Identification Number
Entity Tax Identification Number
Revenues:
Revenues [Abstract]
Percentage of Perpetual Royalty Obligation
Percentage of perpetual royalty obligation.
Percentage of perpetual royalty obligation
Local Phone Number
Local Phone Number
Other current liabilities
Other Liabilities, Current
Accounting Policies [Abstract]
Facilities expense
Facilities expense.
Facilities expense
Disclosure of Product Revenue Reserves and Allowances [Line Items]
Disaggregation Of Revenue [Line Items]
Disaggregation of Revenue [Line Items]
Revenue, Total
Revenue
Revenues
Total revenues
Fifth Amendment Lease Member
Fifth amendment lease member.
Fifth Amendment Lease [Member]
Beginning balance
Ending balance
Contract with Customer, Asset, Allowance for Credit Loss
Lessee, Operating Lease, Liability, to be Paid, Year Four
2029
Commercial Paper [Member]
Commercial Paper [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant
Shares available for grant under the Long Term Incentive Plan
Unrecognized compensation expense weighted average period
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition
Accrued Professional Fees, Current
Professional and legal fees
Cash, Cash Equivalents, and Short-Term Investments, Total
Cash, cash equivalents and investments in marketable securities
Cash, Cash Equivalents, and Short-Term Investments
Equity incentive plan, approval date.
Equity Incentive Plan Approval Date
Equity incentive plan, approval date
Schedule Of Stock By Class [Table]
Stock, Class of Stock [Table]
Entity Emerging Growth Company
Entity Emerging Growth Company